Resultados de procura - Philip Reigan

  • Mostrando 1 - 11 Resultados de 11
Limitar resultados
  1. 1
    Identification of PARN nuclease activity inhibitors by computational-based docking and high-throughput screening

    Identification of PARN nuclease activity inhibitors by computational-based docking and high-throughput screening por Thao Ngoc Huynh, Siddharth Shukla, Philip Reigan, Roy Parker

    Publicado 2023-03-01
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  2. 2
    Evolutionary degeneration of septins into pseudoGTPases: impacts on a hetero-oligomeric assembly interface

    Evolutionary degeneration of septins into pseudoGTPases: impacts on a hetero-oligomeric assembly interface por Alya Hussain, Vu T. Nguyen, Philip Reigan, Michael McMurray

    Publicado 2023-11-01
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  3. 3
    The Lateral Metalation of Isoxazolo[3,4-<i>d</i>]pyridazinones towards Hit-to-Lead Development of Selective Positive Modulators of Metabotropic Glutamate Receptors

    The Lateral Metalation of Isoxazolo[3,4-<i>d</i>]pyridazinones towards Hit-to-Lead Development of Selective Positive Modulators of Metabotropic Glutamate Receptors por Christina A. Gates, Donald S. Backos, Philip Reigan, Nicholas R. Natale

    Publicado 2023-09-01
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  4. 4
    Molecular docking of substituted pteridinones and pyrimidines to the ATP-binding site of the N-terminal domain of RSK2 and associated MM/GBSA and molecular field datasets

    Molecular docking of substituted pteridinones and pyrimidines to the ATP-binding site of the N-terminal domain of RSK2 and associated MM/GBSA and molecular field datasets por Kimberly A. Casalvieri, Christopher J. Matheson, Donald S. Backos, Philip Reigan

    Publicado 2020-04-01
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  5. 5
    Genetic Variants of Lipoprotein Lipase and Regulatory Factors Associated with Alzheimer’s Disease Risk

    Genetic Variants of Lipoprotein Lipase and Regulatory Factors Associated with Alzheimer’s Disease Risk por Kimberley D. Bruce, Maoping Tang, Philip Reigan, Robert H. Eckel

    Publicado 2020-11-01
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  6. 6
    Substituted pteridinones, pyrimidines, pyrrolopyrimidines, and purines as p90 ribosomal S6 protein kinase-2 (RSK2) inhibitors: Pharmacophore modeling data

    Substituted pteridinones, pyrimidines, pyrrolopyrimidines, and purines as p90 ribosomal S6 protein kinase-2 (RSK2) inhibitors: Pharmacophore modeling data por Becka M. Warfield, Kimberly A. Casalvieri, Christopher J. Matheson, Donald S. Backos, Philip Reigan

    Publicado 2021-10-01
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  7. 7
    Characterization of 4-HNE modified L-FABP reveals alterations in structural and functional dynamics.

    Characterization of 4-HNE modified L-FABP reveals alterations in structural and functional dynamics. por Rebecca L Smathers, Kristofer S Fritz, James J Galligan, Colin T Shearn, Philip Reigan, Michael J Marks, Dennis R Petersen

    Publicado 2012-01-01
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  8. 8
    Using Synthetic ApoC-II Peptides and nAngptl4 Fragments to Measure Lipoprotein Lipase Activity in Radiometric and Fluorescent Assays

    Using Synthetic ApoC-II Peptides and nAngptl4 Fragments to Measure Lipoprotein Lipase Activity in Radiometric and Fluorescent Assays por Dean Oldham, Hong Wang, Juliet Mullen, Emma Lietzke, Kayla Sprenger, Philip Reigan, Robert H. Eckel, Kimberley D. Bruce

    Publicado 2022-07-01
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  9. 9
    Auriculocondylar syndrome 2 results from the dominant-negative action of PLCB4 variants

    Auriculocondylar syndrome 2 results from the dominant-negative action of PLCB4 variants por Stanley M. Kanai, Caleb Heffner, Timothy C. Cox, Michael L. Cunningham, Francisco A. Perez, Aaron M. Bauer, Philip Reigan, Cristan Carter, Stephen A. Murray, David E. Clouthier

    Publicado 2022-04-01
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  10. 10
    Neoamphimedine Circumvents Metnase-Enhanced DNA Topoisomerase IIα Activity Through ATP-Competitive Inhibition

    Neoamphimedine Circumvents Metnase-Enhanced DNA Topoisomerase IIα Activity Through ATP-Competitive Inhibition por Philip Reigan, Brian G. Reid, Qiong Zhou, Amanda K. Ashley, Jac A. Nickoloff, Robert Hromas, Daniel V. LaBarbera, Courtney L. Amerin, Qun Li, Adedoyin D. Abraham, Byong Hoon Yoo, Jessica Ponder

    Publicado 2011-11-01
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  11. 11
    A Novel Glucocorticoid and Androgen Receptor Modulator Reduces Viral Entry and Innate Immune Inflammatory Responses in the Syrian Hamster Model of SARS-CoV-2 Infection

    A Novel Glucocorticoid and Androgen Receptor Modulator Reduces Viral Entry and Innate Immune Inflammatory Responses in the Syrian Hamster Model of SARS-CoV-2 Infection por Savannah M. Rocha, Savannah M. Rocha, Anna C. Fagre, Amanda S. Latham, Amanda S. Latham, Jason E. Cummings, Tawfik A. Aboellail, Philip Reigan, Devin A. Aldaz, Casey P. McDermott, Katriana A. Popichak, Rebekah C. Kading, Tony Schountz, Neil D. Theise, Richard A. Slayden, Ronald B. Tjalkens

    Publicado 2022-02-01
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:

Ferramentas de procura: